全文获取类型
收费全文 | 6091篇 |
免费 | 394篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 196篇 |
妇产科学 | 139篇 |
基础医学 | 1056篇 |
口腔科学 | 67篇 |
临床医学 | 685篇 |
内科学 | 1132篇 |
皮肤病学 | 187篇 |
神经病学 | 558篇 |
特种医学 | 129篇 |
外科学 | 498篇 |
综合类 | 79篇 |
一般理论 | 4篇 |
预防医学 | 780篇 |
眼科学 | 170篇 |
药学 | 313篇 |
中国医学 | 17篇 |
肿瘤学 | 463篇 |
出版年
2023年 | 52篇 |
2022年 | 64篇 |
2021年 | 155篇 |
2020年 | 86篇 |
2019年 | 118篇 |
2018年 | 154篇 |
2017年 | 122篇 |
2016年 | 147篇 |
2015年 | 160篇 |
2014年 | 217篇 |
2013年 | 323篇 |
2012年 | 402篇 |
2011年 | 487篇 |
2010年 | 261篇 |
2009年 | 244篇 |
2008年 | 423篇 |
2007年 | 370篇 |
2006年 | 396篇 |
2005年 | 428篇 |
2004年 | 349篇 |
2003年 | 340篇 |
2002年 | 299篇 |
2001年 | 58篇 |
2000年 | 49篇 |
1999年 | 44篇 |
1998年 | 60篇 |
1997年 | 51篇 |
1996年 | 44篇 |
1995年 | 41篇 |
1994年 | 39篇 |
1993年 | 46篇 |
1992年 | 32篇 |
1991年 | 25篇 |
1990年 | 25篇 |
1989年 | 18篇 |
1988年 | 24篇 |
1987年 | 12篇 |
1986年 | 14篇 |
1985年 | 20篇 |
1984年 | 23篇 |
1983年 | 19篇 |
1982年 | 23篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 12篇 |
1978年 | 12篇 |
1976年 | 15篇 |
1975年 | 23篇 |
1974年 | 14篇 |
1973年 | 17篇 |
排序方式: 共有6501条查询结果,搜索用时 0 毫秒
101.
Buscatti Izabel M. Casella Beatriz B. Aikawa Nadia E. Watanabe Andrea Farhat Sylvia C. L. Campos Lucia M. A. Silva Clovis Artur 《Clinical rheumatology》2018,37(5):1325-1325
Clinical Rheumatology - One of the author’s name on this article was incorrectly spelled as “Sylvia C. L. Fahrat” . The correct spelling is “Sylvia C. L. Farhat” and... 相似文献
102.
Xiaolei Ze Fanny Le Mougen Sylvia H. Duncan Petra Louis Harry J. Flint 《Gut microbes》2013,4(3):236-240
The microbial communities found in the mammalian large intestine and rumen efficiently degrade many recalcitrant substrates that are resistant to the host’s digestive enzymes. These communities are known from molecular profiling to be highly diverse at the species and strain level, but it may be that only certain specialized organisms (“keystone species”) have the ability to initiate degradation of such substrates, thus releasing energy on which the rest of the community depends. We have recently reported that Ruminococcus bromii has a superior ability to degrade certain forms of particulate resistant starch (RS) when compared with other highly abundant species of amylolytic bacteria found in the human colon and have presented evidence that this bacterium provides an example of a keystone species within the microbial community with respect to RS fermentation. The concept of keystone species can be equally relevant to other activities, e.g., those involved in stabilizing the community. 相似文献
103.
104.
105.
Sylvia Baumann Kurer Burkhardt Seifert Beat Michel† Regula Ruegg Jörg Fehr 《British journal of haematology》1995,91(4):820-826
Summary. We prospectively studied 45 anaemic patients (3 7 women, 8 men) with chronic inflammatory rheumatic diseases. The combination of serum ferritin and CRP (as well as ESR) in its predictive capacity for bone marrow iron stores was examined. The relationship between other iron-related measurements (transferrin, transferrin saturation, soluble transferrin receptor, erythrocyte porphyrins and percentage of hypochromic/microcytic erythrocytes) and bone marrow iron stores was also investigated. Stainable bone marrow iron was taken as the most suitable standard to separate iron-deficient from iron-replete patients. 14 patients (31%) were lacking bone marrow iron. Regression analysis showed a good correlation between ferritin and bone marrow iron (adjusted R 2 =0.721, P<00001). The combination of ferritin and CRP (ESR) did not improve the predictive power for bone marrow iron (adjusted R 2 =0.715) in this cohort of patients with low systemic inflammatory activity. With respect to the bone marrow iron content the best predictive cut-off value of ferritin was 30μg/l (86% sensitivity, 90% specificity). The other iron-related parameters both individually and when combined were less powerful in predicting bone marrow iron than ferritin alone. Only zinc bound erythrocyte protoporphyrin in combination with ferritin slightly improved prediction (adjusted R 2 =0.731). A cut-off point of 11% hypochromic erythrocytes reached a high specificity (90%), but was less sensitive (77%). 相似文献
106.
107.
Kim CK McGorray SP Bartholomew BA Marsh M Dicken T Wassertheil-Smoller S Curb JD Oberman A Hsia J Gardin J Wong ND Barton B McMahon RP Sheps DS 《Archives of internal medicine》2005,165(11):1239-1244
BACKGROUND: Depressive symptoms have been associated with increased cardiac morbidity and mortality rates, but the pathophysiologic mechanism linking depressive symptoms to cardiovascular outcome has yet to be fully understood. Lower heart rate variability has also been associated with increased risk of cardiac events in healthy individuals and in patients with coronary artery disease. Findings regarding a relationship between depressive symptoms and heart rate variability that could explain increased cardiovascular risk have been inconsistent across studies. METHODS: As an ancillary study to the Women's Health Initiative Observational Study, 3372 postmenopausal women aged 50 to 83 years were enrolled for further evaluation using 24-hour ambulatory electrocardiographic monitoring. A shortened version of the Center for Epidemiological Studies Depression Scale and the Diagnostic Interview Schedule were administered. Women with adequate electrocardiographic data and depressive symptom information and without coronary artery disease were analyzed (n = 2627). RESULTS: Two hundred sixty-nine women (10.2%) had depressive symptoms as measured using the 2 instruments. Women with depressive symptoms had a higher mean +/- SD heart rate (77.4 +/- 9.6 vs 75.5 +/- 8.5 beats/min) and lower heart rate variability than women without depressive symptoms. All differences remained significant after adjusting for age (P<.01). CONCLUSIONS: Women with depressive symptoms had significant reductions in heart rate variability and higher heart rates, suggestive of increased sympathetic tone. These findings may contribute to the increased cardiac morbidity and mortality rates associated with depression in other studies. 相似文献
108.
Antisera with la Specificity Selected by Lymphocytes from Patients with Chronic Lymphocytic Leukemia
Sylvia D. Lawler P. J. Dewar Ivanka Mrazek Elizabeth H. Jones and A. B. Hockley 《Vox sanguinis》1978,34(4):200-207
Cells from patients with chronic lymphocytic leukaemia (CLL) have been used to screen the sera of pregnant women for antibodies specifc for B lymphocytes. The sera have been divided into groups showing Ig specificity: group I (UK 3) had a positive association with HLA-B8 and DW3, and group II (UK 2) with HLA-B7 and DW2. Groups III, IV and X were independent of each other and of HLA-A, B and C locus antigens. Certain sera with B-cell activity showed specific blocking activity in the mixed lymphocyte reaction (MLR), and this activity was dependent on the Ia sepcificities and DW specificities of cells used in the MLR. Some sera specifically blocked the responding cells, other the stimulating cells. 相似文献
109.
Malek Kamoun John H. Holmes Ajay K. Israni Jane D. Kearns Valerie Teal Wei Peter Yang Sylvia E. Rosas Marshall M. Joffe Hongzhe Li Harold I. Feldman 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(48):18883-18888
Delayed allograft function (DGF) is a common adverse event in postrenal transplantation. The etiology of DGF is thought to include both nonimmunologic (donor age, cold ischemia time, and recipient race) and immunologic factors. We examined the association of DGF with amino acid mismatches at 66 variable sites of the HLA-A molecule in a prospective cohort study of 697 renal transplant recipients of deceased donors. Using a multivariate logistic regression model adjusted for nonimmunologic risk factors, we show that combinations of a few amino acid mismatches at crucial sites of HLA-A molecules were associated with DGF. In Caucasian recipients, a mismatch at position 62, 95, or 163, all known to be functionally important within the antigen recognition site, was associated with an increased risk for DGF. Furthermore, a decreased risk for DGF was associated with a mismatch at HLA-A family-specific sites (149, 184, 193, or 246), indicating that evolutionary features of HLA-A polymorphism separating HLA-A families and lineages among donor-recipient pairs may correlate with the magnitude of alloreactivity influencing the development of DGF. These findings suggest that amino acid polymorphisms at functionally important positions at the antigen recognition site of the HLA-A molecule have a significant influence on DGF. 相似文献
110.
Koren-Michowitz M Dishy V Zaidenstein R Yona O Berman S Weissgarten J Golik A 《American journal of hypertension》2005,18(3):358-363
BACKGROUND: Thiazide diuretics and angiotensin-converting enzyme inhibitors can cause excessive urinary zinc (Zn) loss and Zn depletion. Thiazides may also induce magnesium (Mg) deficiency, which may exacerbate hypertension. Data on the effects of angiotensin receptor blockers on Zn and Mg homeostasis are scarce. METHODS: Seventeen hypertensive patients were studied (ten men and seven women, age 50 +/- 3 years, blood pressure 158 +/- 5 / 95 +/- 3 mm Hg). Patients were treated with losartan 50 mg/day for 4 weeks followed by a fixed combination of 50 mg losartan and 12.5 mg hydrochlorothiazide for 4 weeks more. Blood and 24-h urine were collected at baseline and after each study period. Zinc and Mg levels were measured in serum, urine, and peripheral blood mononuclear cells. Nitric oxide metabolites were measured in urine. RESULTS: Treatment with losartan resulted in a significant increase in the urinary Zn/creatinine ratio (from 0.020 +/- 0.004 microg/mg to 0.034 +/- 0.005 microg/mg, P = .02), which was further increased by the losartan/hydrochlorothiazide combination (from 0.034 +/- 0.005 microg/mg to 0.053 +/- 0.008 microg/mg, P = .03). Serum Zn levels were significantly decreased after losartan/hydrochlorothiazide (from 80.0 +/- 4.0 microg/dL at baseline to 74.0 +/- 3.0 microg/dL, P = .007). Peripheral blood mononuclear Zn concentrations were decreased also, but this was not statistically significant. Serum, urinary, and peripheral blood mononuclear Mg levels were not significantly affected by treatment. Nitric oxide urinary metabolites were unchanged throughout the study. CONCLUSIONS: Treatment with losartan causes an increase in urinary Zn excretion and induces Zn deficiency in patients with hypertension. The addition of hydrochlorothiazide has an additive effect. Magnesium and nitric oxide metabolism are not affected by either treatment. 相似文献